Rhumbline Advisers Has $4.41 Million Holdings in Roche Holding AG (OTCMKTS:RHHBY)

Rhumbline Advisers grew its stake in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 7.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 107,252 shares of the company's stock after acquiring an additional 7,374 shares during the period. Rhumbline Advisers' holdings in Roche were worth $4,413,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. HighPoint Advisor Group LLC boosted its position in shares of Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock valued at $387,000 after acquiring an additional 304 shares during the period. SVB Wealth LLC bought a new position in shares of Roche during the fourth quarter worth approximately $555,000. Confluence Investment Management LLC increased its holdings in shares of Roche by 3.6% during the first quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after purchasing an additional 510 shares during the period. Minot DeBlois Advisors LLC bought a new position in shares of Roche during the fourth quarter worth approximately $752,000. Finally, Hancock Whitney Corp increased its holdings in shares of Roche by 6.8% during the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after purchasing an additional 1,496 shares during the period.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on RHHBY shares. Hsbc Global Res downgraded Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. HSBC cut Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".

Roche Price Performance

Shares of RHHBY opened at $41.32 on Friday. Roche Holding AG has a one year low of $33.76 and a one year high of $44.31. The firm has a 50 day simple moving average of $39.48 and a two-hundred day simple moving average of $39.03. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.